No Effect of Aprotinin (Trasylol™) on Degradation of Exogenous and Endogenous Glucagon in Human, Mouse and Rat Plasma

Journal Title: Journal of Endocrinology and Diabetes - Year 2014, Vol 1, Issue 1

Abstract

Traditionally, aprotinin (Trasylol™) has been added to plasma samples prior to glucagon analysis. However, the evidence for the need of aprotinin is sparse and based on results obtained when radioimmunoassay (RIA) techniques were still in their infancy. Using RIAs directed against both the C-terminus and a mid-region of glucagon, we challenged the classical view that aprotinin is necessary. Glucagon concentrations in pools of human, mouse and rat plasma (n=30, 25 and 16 of each, respectively) with and without addition of increasing amounts of exogenous glucagon (5, 10, 20, 40 and 60 pM) were similar irrespective of whether or not aprotinin had been added. To investigate whether individual variation occurs in human samples, we measured plasma from 20 patients with gastrointestinal diseases and 20 healthy subjects with or without addition of aprotinin. Again, measured amounts of glucagon, endogenous or added, were not affected by the presence of aprotinin. The effect of aprotinin, present at blood sampling or added later (30 and 60 minutes), on endogenous glucagon values was investigated in T2DM patients (n=5), before and after insulin-induced hypoglycemia. There were no differences between the four treatments. In conclusion, we found no support for use of aprotinin for prevention of glucagon degradation.

Authors and Affiliations

Jens Juul Holst, Monika J Bak, Nicolai Wewer Albrechtsen, Jens Pedersen, Bolette Hartmann, Mikkel Christensen, Tina Vilsbøll, Filip Knop, Lars O Dragsted

Keywords

Related Articles

Several Types of Somatic Mutations Induce Autonomous Production of Aldosterone in Primary Aldosteronism

It is well known that primary aldosteronism (PA) is the most common form of secondary hypertension, and also that aldosterone-producing adenoma (APA) and bilateral hyperaldosteronism (idiopathic hyperaldosteronism: IHA)...

Brachial-ankle Pulse Wave Velocity and Renal Function can Predict Coronary Artery Disease in Asymptomatic Japanese Patients with Type 2 Diabetes

In patients with diabetes mellitus, myocardial perfusion defects are often observed in the absence of obstructive Coronary Artery Disease (CAD), thereby presenting a diagnostic problem. Meanwhile, the indications for Mul...

A New Diagnosis of Addison's Disease with a Twist

Addison's disease is a rare autoimmune endocrine disorder. It affects the cortex of the adrenal glands causing cortisol, aldosterone and adrenal androgen deficiencies. Addison's disease usually presents with non specific...

Association of Diabetic Retinopathy and Maculopathy with Elevated HbA1c, Blood Pressure, Serum Creatinine, Microalbuminuria, Spot Urine Protein, Nephropathy and Diabetic Kidney Disease. An Experience from Data Analysis of 10,580 Diabetic Patients

Background: Diabetic kidney disease and retinopathy are the most important complications which usually co-exist together with high economic cost, morbidity, and mortality. Current research was designed to study these two...

Social Representations of Feeding People with Type-2 Diabetes Mellitus

The aim of this study was to analyze the social representations of the diets 34 patients of the Brazilian public primary care service diagnosed with type- 2 diabetes mellitus, according to how they represent their identi...

Download PDF file
  • EP ID EP332837
  • DOI 10.15226/2374-6890/1/1/00101
  • Views 139
  • Downloads 0

How To Cite

Jens Juul Holst, Monika J Bak, Nicolai Wewer Albrechtsen, Jens Pedersen, Bolette Hartmann, Mikkel Christensen, Tina Vilsbøll, Filip Knop, Lars O Dragsted (2014). No Effect of Aprotinin (Trasylol™) on Degradation of Exogenous and Endogenous Glucagon in Human, Mouse and Rat Plasma. Journal of Endocrinology and Diabetes, 1(1), 1-5. https://europub.co.uk/articles/-A-332837